5Hamanaka RB, Chandel NS. Targeting glucose metabolism for cancer therapy[J].J Exp Med,2012,209(2):211-215.
6Airley RE,Mobasheri A.Hypoxic regulation of glucose transport,anaerobic metabolism and angiogenesis in cancer:novel pathways and targets for anticancer therapeutics[J].Chemotherapy,2007,53(4):233-256.
7Macheda ML,Rogers S,Best JD.Molecular and cellular regulation of glucose transporter(GLUT)proteins in cancer[J].J Cell Physiol,2005,202(3):654-662.
8Chan DA,Sutphin PD,Nguyen P,et al.Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality[J].Sci Transl Med,2011,3(94):70-94.
9Robey RB,Hay N.Mitochondrial hexokinases,novel mediators of the antiapoptotic effects of growth factors and Akt[J].Oncogene,2006,25(34):4683-4696.
10Jae HJ,Chung JW,Park HS,et al.The antitumor effect and hepatotoxicity of a hexokinase II inhibitor 3-bromopyruvate:in vivo investigation of intraarterial administration in a rabbit VX2 hepatoma model[J].Korean J Radiol,2009,10(6):596-603.
